KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies.RMD Open已检查 6 张 PubMed Figure,均未识别为 KM 图:Figure 1:ROC 图;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other;Figure 5:ROC 图;另有 1 张未列出。PMID 41506743PMC130599022026-Jan-080.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial.Nat Commun已检查 2 张 PubMed Figure,均未识别为 KM 图:Fig. 1:AI 判定为 flow diagram;Fig. 2:AI 判定为 other。PMID 41501026PMC128813902026-Jan-070.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial.Br J Dermatol入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40668972无 PMCID2026-Jan-060.98未发现恶性肿瘤人群证据。无 KM 图
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement.Br J DermatolPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40875818无 PMCID2026-Jan-060.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.Endocr J疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 6 张 PMC Figure,均未识别为 KM 图:Fig. 1:非 KM 图;Fig. 2:非 KM 图;Fig. 3:非 KM 图;Fig. 4:非 KM 图;Fig. 5:非 KM 图;另有 1 张未列出。PMID 41183961PMC128190712026-Jan-060.98未发现恶性肿瘤人群证据。无 KM 图
Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.JAMA疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 41324946PMC126702622026-Jan-060.98未发现恶性肿瘤人群证据。无 KM 图
Differential Effect of Ticagrelor Versus Clopidogrel by Causative Classification of Stroke Classification and Vascular Cellular Adhesion Molecule-1 Level on the Risk of Recurrent Stroke: A Post Hoc Analysis of the CHANCE-2 Trial.J Am Heart AssocPMID 41413755PMC129090132026-Jan-060.98未发现恶性肿瘤人群证据。已完成
Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants.VaccinePubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41319434无 PMCID2026-Jan-050.98未发现恶性肿瘤人群证据。无 KM 图
Exploring Trial Endpoints in Geographic Atrophy Based on Localized Functional Changes in Microperimetry and AI-Quantified OCT Biomarkers.Invest Ophthalmol Vis Sci疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 4 张 PMC Figure,均未识别为 KM 图:Figure 1.:非 KM 图;Figure 2.:非 KM 图;Figure 3.:非 KM 图;Figure 4.:非 KM 图。PMID 41533918PMC128059682026-Jan-050.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.LancetPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41314226无 PMCID2026-Jan-030.98未发现恶性肿瘤人群证据。无 KM 图
Long-Term Survival Outcomes of NCRT With Surgery vs Surgery With Adjuvant Therapy for ESCC: A Single-Center Prospective Phase 3 Randomized Clinical Trial.JAMA Netw OpenPMID 41490111PMC127712562026-Jan-020.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。已完成
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis.Hepatology入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40053863PMC124431612026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.Ann SurgPMID 40235447PMC126952942026-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine.Pain Med已检查 3 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 flow diagram;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other。PMID 40627411PMC127737422026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Randomized, double-blind phase III trial of a dexamethasone-free regimen for managing highly emetogenic chemotherapy-induced nausea and vomiting.Int J CancerPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40735921无 PMCID2026-Jan-010.95While the record meets criteria for oncology, human, randomized, phase III, drug intervention, and original result, it fails the core eligibility requirement of having a primary/key secondary time-to-event efficacy endpoint. The primary endpoint is a binary response rate (complete response rate), and no time-to-event analysis (e.g., Kaplan-Meier, HR) is mentioned for any endpoint.无 KM 图
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial.Int J Radiat Oncol Biol Phys疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40752655无 PMCID2026-Jan-010.90The record describes a Phase III randomized trial in breast DCIS with a time-to-event primary endpoint. However, the intervention is radiation therapy (a non-drug technique), and the reported results are for secondary endpoints (toxicity and quality of life). The eligibility criteria require a drug-containing intervention and an original report of the primary or key secondary efficacy endpoint. This report does not meet the drug intervention criterion.无 KM 图
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-Risk Patients With Breast Cancer (HYPART): Acute Toxicity Results.Int J Radiat Oncol Biol PhysPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40780546无 PMCID2026-Jan-010.95The record is from a definitive Phase III randomized oncology trial in humans, but it reports only acute toxicity results and does not include the survival or time-to-event efficacy outcomes required for the Kaplan-Meier digitization cohort.无 KM 图
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial.HaematologicaPMID 40820816PMC127757672026-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016.Int J Radiat Oncol Biol Phys疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 2 张 PMC Figure,均未识别为 KM 图:Figure 1:非 KM 图;Figure 2.:非 KM 图。PMID 40829719PMC126370332026-Jan-010.85The report is from a Phase III randomized oncology trial with drug intervention, but the reported results are for a patient-reported secondary endpoint (hearing handicap), not a time-to-event efficacy endpoint. The deterministic review correctly identified no time-to-event signal.无 KM 图
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting.J RheumatolPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40953957无 PMCID2026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative Colitis.Inflamm Bowel Dis疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 2 张 PMC Figure,均未识别为 KM 图:Figure 1.:非 KM 图;Figure 2.:非 KM 图。PMID 40997114PMC127590552026-Jan-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。无 KM 图
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid.Inflamm Bowel Dis疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 6 张 PMC Figure,均未识别为 KM 图:Figure 1.:AI 判定为 flow diagram;Figure 2.:非 KM 图;Figure 3.:非 KM 图;Figure 4.:非 KM 图;Figure 5.:非 KM 图;另有 1 张未列出。PMID 41003640PMC127590512026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Early palliative care for patients with glioblastoma: A randomized phase III clinical trial (EPCOG).Neuro OncolPMID 41071052PMC129626462026-Jan-010.95The study is a Phase III randomized trial in glioblastoma (oncology, human), but it fails two key eligibility criteria: 1) The primary endpoint is quality-of-life (FACT-Br), not a time-to-event efficacy endpoint. 2) The intervention is early palliative care (non-drug), not a drug-containing regimen. Therefore, it is not eligible for the oncology KM digitization cohort.已完成
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.N Engl J Med疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 41104938无 PMCID2026-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.N Engl J Med疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 41124220无 PMCID2026-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.J Hypertens疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:FIGURE 1:森林图/亚组分析图;FIGURE 2:非 KM 图;FIGURE 3:AI 判定为 other。PMID 41195725PMC126720292026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.JAMA Cardiol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 4 张 PMC Figure,均未识别为 KM 图:Figure 1.:森林图/亚组分析图;Figure 2.:森林图/亚组分析图;Figure 3.:生活质量量表图;Figure 4.:非 KM 图。PMID 41205147PMC125967432026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.VaccinePubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41223690无 PMCID2026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of clevidipine emulsion injection compared with nicardipine in patients with hypertensive emergencies: a randomized, single-blind, positive-parallel-controlled, phase III clinical trial.J HypertensPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41231022无 PMCID2026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trial.Vaccine疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 41337911无 PMCID2026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial.J Chin Med Assoc疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Fig. 1:非 KM 图;Fig. 2:非 KM 图。PMID 41396155PMC128155232026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.Cancer疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 41420831无 PMCID2026-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants.J Drugs DermatolPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41493257无 PMCID2026-Jan-010.98未发现恶性肿瘤人群证据。无 KM 图
Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602).Endocr Relat CancerPMID 41524552PMC128722962026-Jan-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。已完成
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.Nat Med入排复审未纳入:未发现恶性肿瘤人群证据。PMID 41495411PMC128234172026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial.JACC Heart FailPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40208137无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study.JACC Heart FailPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40338768无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Systemic Inflammatory Markers Correlate with Chronic Kidney Disease-Associated Pruritus and Response to Treatment.J Invest Dermatol入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40409676无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
A clinical study of ten-year prognosis in patients with lumbar disc herniation treated with condoliase in a phase III trial.J Orthop SciPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40664535无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials.Fertil SterilPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40714031无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan.Mov Disord Clin Pract入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40771035PMC128394942026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.Aliment Pharmacol Ther已检查 4 张 PubMed Figure,均未识别为 KM 图:FIGURE 1:AI 判定为 other;FIGURE 2:AI 判定为 multi panel km;FIGURE 3:AI 判定为 other;FIGURE 4:AI 判定为 other。PMID 40793974PMC126902282026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.OphthalmologyPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40816607无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Comparison of patient-reported outcomes in patients achieving complete versus near-complete skin clearance following Vunakizumab treatment: a post-hoc analysis of a phase III trial.Naunyn Schmiedebergs Arch Pharmacol入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40853464无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.OphthalmologyPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40876598无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Perfluorohexyloctane Eye Drops in Premenopausal and Postmenopausal Women with Dry Eye Disease Associated with Meibomian Gland Dysfunction: A Post Hoc Analysis of a Phase 3 Trial.Curr Eye ResPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40898391无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Pooled data from phase 3 clinical trials comparing the clinical activity of ceftolozane/tazobactam versus meropenem for the treatment of complicated intra-abdominal infections.Infect Dis (Lond)PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40913503无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial.Lancet Infect DisPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40945526无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial.Clin Microbiol InfectPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40962113无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial.J Am Acad DermatolPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40976531无 PMCID2026-Jan0.98未发现恶性肿瘤人群证据。无 KM 图